Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.
Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, San Francisco, CA, USA.
Daniel L
DL
Faden
Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California, San Francisco, CA, USA.
Alain
A
Algazi